Anticardiolipin antibodies (aCL): Titre, avidity and anti-beta 2 glycoprotein-I (beta 2GPI) specificity

被引：0
|
作者：
Vlachoyiannopoulos, PG [1 ]
Tektonidou, M [1 ]
Petrovas, C [1 ]
Dafni, U [1 ]
Moutsopoulos, HM [1 ]
机构：
[1] NATL UNIV ATHENS,SCH MED,DEPT PATHOPHYSIOL,ATHENS,GREECE
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1613 / 1613
页数：1
相关论文
共 50 条
  • [21] THE USE OF AN ANTI-BETA(2)-GLYCOPROTEIN-I ASSAY FOR DISCRIMINATION BETWEEN ANTICARDIOLIPIN ANTIBODIES ASSOCIATED WITH INFECTION AND INCREASED RISK OF THROMBOSIS
    MCNALLY, T
    PURDY, G
    MACKIE, IJ
    MACHIN, SJ
    ISENBERG, DA
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 471 - 473
  • [22] RESISTANCE TO ACTIVATED PROTEIN-C ACTIVITY OF AN ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODY IN THE PRESENCE OF BETA(2)-GLYCOPROTEIN-I
    MATSUDA, J
    GOTOH, M
    GOHCHI, K
    KAWASUGI, K
    TSUKAMOTO, M
    SAITOH, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) : 204 - 206
  • [23] Anti-beta 2 glycoprotein I antibodies in centenarians
    Meroni, PL
    Mari, D
    Monti, D
    Coppola, R
    Capri, M
    Salvioli, S
    Tincani, A
    Gerli, R
    Franceschi, C
    EXPERIMENTAL GERONTOLOGY, 2004, 39 (10) : 1459 - 1465
  • [24] Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab
    Sciascia, Savino
    Rubini, Elena
    Radin, Massimo
    Cecchi, Irene
    Rossi, Daniela
    Roccatello, Dario
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1693 - +
  • [25] RELATIONSHIP BETWEEN ANTICARDIOLIPIN, ANTIENDOTHELIAL-CELL AND ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES IN HIV-INFECTED INDIVIDUALS
    WEISS, L
    YOU, JF
    GIRAL, P
    ALHENCGELAS, M
    KAZATCHKINE, MD
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1995, 37 : S83 - S86
  • [26] Anticardiolipin and anti-beta(2)glycoprotein-I antibodies: Prevalence and isotype distribution in 3 geographic populations of patients with SLE.
    Cucurull, E
    Mendez, E
    Molina, JF
    Celli, CM
    OrdiRos, J
    Espinoza, LR
    Gharavi, AE
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 449 - 449
  • [27] Anti-beta(2)-glycoprotein I antibodies, anticardiolipin antibodies and lupus anticoagulant in haemodialysis patients.
    GarciaMartin, F
    Piqueras, JA
    Pinedo, B
    deArriba, G
    Teruel, JL
    Sanchez, M
    Jarillo, MD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2633 - A2633
  • [28] Anticardiolipin (ACL) and anti-β2 glycoprotein 1 (Aβ2GPI) antibodies in SLE patients with nephritis.
    Diri, E
    Gharavi, AE
    Gedalia, A
    Hoffmann, EO
    Cucurull, E
    Mendez, AE
    Espinoza, LR
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S312 - S312
  • [29] Anticardiolipin and anti-beta 2-glycoprotein I antibodies in patients with unexplained articular manifestations
    Melayah, Sarra
    Ghozzi, Mariem
    Ghedira, Ibtissem
    Mankai, Amani
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [30] SYNCHRONIZED INHIBITION OF THE PHOSPHOLIPID MEDIATED AUTOACTIVATION OF FACTOR-XII IN PLASMA BY BETA(2)-GLYCOPROTEIN-I AND ANTI-BETA(2)-GLYCOPROTEIN-I
    SCHOUSBOE, I
    RASMUSSEN, MS
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (05) : 798 - 804
12345